RGEN
#922
Repligen Corporation - Common Stock
176.2 7 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.16%
Monthly Change
+22.57%
6 month change
+39.60%
Year Change
+6.39%
Previous Close
182.0 3
Open
176.2 7
Low
176.2 7
High
176.2 7
Volume
106
Financials
- Market Capitalization 9.95 B
- Employee 2 000
- Founded 1981
- CEO Tony J. Hunt
- Website www.repligen.com
- Headquarter Delaware, United States
- FIGI BBG000BS48J3
- Industry Medical Instruments & Supplies
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
190.53
Price to sales ratio
0.01
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 758 |  BAX Baxter International Inc. Common Stock | 26.13 USD | +0.77% | -1.10% | -3.22% | +6.87% | 13.51 B USD | ||
| 859 |  ALGN Align Technology, Inc. - Common Stock | 157.58 USD | -0.79% | -2.88% | -7.75% | -17.05% | 11.19 B USD | ||
| 1017 |  ATR AptarGroup, Inc. Common Stock | 132.97 USD | +0.13% | -1.87% | -2.63% | -3.84% | 8.45 B USD | ||
| 1178 |  STVN Stevanato Group S.p.A. Ordinary Shares | 21.08 USD | -5.51% | -6.48% | +3.84% | -6.31% | 6.38 B USD |
Frequently asked questions about Repligen Corp
What is the Repligen Corp stock price today?
The current price of Repligen Corp (RGEN) is 176.27. Over the past 24 hours, the stock has changed by -3.16%. Follow the RGEN chart for real-time price dynamics.
What is the stock ticker of Repligen Corp?
Repligen Corp trades under the ticker RGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Repligen Corp stock going up?
RGEN has changed by -2.40% over the last week, +22.57% over the last month, and +6.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Repligen Corp?
Repligen Corp currently has a market capitalization of 9.95 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Repligen Corp earnings last quarter?
Last quarter, Repligen Corp reported earnings of 0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Repligen Corp revenue for the last quarter?
Repligen Corp reported quarterly revenue of 204.13 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Repligen Corp net income for the last quarter?
Repligen Corp reported net income of 5.01 M for the last quarter. The previous quarter showed 8.33 M, which means net income changed by -39.90%.
How many employees does Repligen Corp have?
As of the latest available data, Repligen Corp has 2 000 employees. Workforce size can provide additional context about the company's scale and operations.
What is Repligen Corp EBITDA?
Repligen Corp EBITDA is 27.94 M, and its EBITDA margin is 13.69%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Repligen Corp stock?
You can buy Repligen Corp (RGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Repligen Corp stock?
Investing in Repligen Corp requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RGEN chart and related analysis on metatrader.com as part of your research.